From Liston Street Pulse:
Shares of Oncolytics Biotech Inc. (ONCY), a development stage company focused on research and development of a cancer therapeutic, have risen sharply in trading today after the company announced final tumor response data from its U.S. Phase 2 single arm clinical trial in patients with squamous cell carcinoma of the […]
The post Oncolytics Biotech Reports Positive Trial Data appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015